The Starr Foundation Launches Multi-Institutional Cancer Consortium
The Starr Foundation today announced that it has made a $100 million grant to create a wide-ranging cancer consortium to coordinate the efforts of five internationally renowned research institutions in the fight against cancer. Joining this ambitious undertaking are The Broad Institute of MIT and Harvard, Cold Spring Harbor Laboratory, Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College.
New Milestones in Cancer Research and Education at Memorial Sloan-Kettering
Memorial Sloan-Kettering Cancer Center is now poised to take greater advantage of a new era in cancer research and education with the opening of a state-of-the-art research center, the establishment of a new graduate school, and the founding of a novel research program in human oncology.
Long-term Outcomes for Prostate Cancer Show Intensity Modulated Radiation Therapy Curative: 89 Percent of Men Disease-Free Eight Years Later
Results from the largest study of men with prostate cancer treated with high-dose, intensity modulated radiation therapy (IMRT) show that the majority of patients remain alive with no evidence of disease after an average follow-up period of eight years.
Investigators Create New Mouse Models for Lung Cancer that Mimic Human Disease
Memorial Sloan-Kettering Cancer Center investigators have created two new mouse models of lung adenocarcinoma. The models were developed based on previous studies carried out at Memorial Sloan-Kettering and elsewhere that identified mutations in the epidermal growth factor receptor (EGFR) gene in approximately 10 percent of US cases of lung adenocarcinoma, the most common form of lung cancer.
About Herbs, Botanicals & Other Products
Presented by our Integrative Medicine Service, these pages provide evidence-based information about herbs, botanicals, supplements, and more.
